Tradestie Institutional Equity Comparison Engine · Market Close Nov 16, 2026

SENS vs CRNT: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

CRNT Wins Head-to-Head Institutional Verdict (4–2 across 6 Pillars · 6–4 Matrix Metrics)

CRNT Overall Winner 6-Pillar Tally: SENS 2 – 4 CRNT Matrix Metrics: SENS 4 – 6 CRNT

As of Nov 16, 2026, Ceragon Networks Ltd (CRNT) is the stronger overall head-to-head candidate over Senseonics Holdings, Inc. (SENS) in the Tradestie Institutional Equity Comparison Engine, winning 6–4 core matrix metrics and 4–2 across our 6-pillar institutional scorecard (led by Valuation Multiples, Profitability & Quality, Balance Sheet & Cash Flow). SENS carries a Unified Composite Score of 38.8/100 (SELL) at $11.03 (21.0x Forward P/E, -201.0% operating margin), whereas CRNT carries 26.6/100 (SELL) at $2.36 (13.7x Forward P/E, 3.5% operating margin).

  • Composite vs. Pillar Nuance: While SENS currently prints a higher short-term Unified Composite Score (38.8/100 SELL vs. CRNT 26.6/100 SELL), CRNT captures the overall institutional head-to-head verdict (6–4 matrix metrics and 4–2 across the 6 pillars) due to superior fundamental profitability (3.5% vs. -201.0% operating margin) and revenue trajectory (+11.7% vs. +141.6% YoY).
  • Defensive Composite Rating Caution: Although CRNT compares more favorably head-to-head, both SENS (38.8/100 SELL) and CRNT (26.6/100 SELL) currently screen in defensive SELL territory (<42/100) on our Unified Composite model.
  • Technical & Structure Timing Caution: SENS trades in a Markup technical trend (CONSOLIDATION options phase, RSI 66.7); meanwhile CRNT is in a Breakdown options structure phase (RSI 56.2). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About SENS vs CRNT
SENS NYSE American
Senseonics Holdings, Inc.
Industrial Instruments For Measurement, Display, And Control
$11.03
+4.25% 1D
Market Cap $569.4M
TTM Revenue $60M
Forward P/E 21.0x
Beta / 30D Vol 1.96β · 102% Vol
Unified Composite Score
38.8 / 100 SELL
Tech 15.0 Fund 43.0 Flow 57.0 Mom 70.0
Weinstein Technical Phase Markup · Hold / add on dips
Price above SMA50, rising 50-day trend (0.6% over 20 days), RSI 67
RSI-14: 66.7 · SMA20: $9.06 · SMA50: $9.21
CRNT NASDAQ Head-to-Head Winner
Ceragon Networks Ltd
Radio & Tv Broadcasting & Communications Equipment
$2.36
-1.26% 1D
Market Cap $217.2M
TTM Revenue $357M
Forward P/E 13.7x
Beta / 30D Vol 1.84β · 77% Vol
Unified Composite Score
26.6 / 100 SELL
Tech 50.0 Fund 35.0 Flow 58.0 Mom 50.0
Weinstein Technical Phase Markup · Hold / add on dips
Price above SMA50, rising 50-day trend (1.5% over 20 days), RSI 56
RSI-14: 56.2 · SMA20: $2.19 · SMA50: $2.12

6-Pillar Scorecard Institutional Category Breakdown (SENS 2 – 4 CRNT)

Columns: Metric · SENS · CRNT
1. Valuation Multiples CRNT
Forward P/E 21.0x 13.7x
Trailing P/E 21.0x 15.7x
PEG Ratio N/M 8.80x
EV / Revenue 9.7x 0.6x
2. Growth & Scale SENS
Revenue Growth (YoY) +141.6% +11.7%
Earnings Growth (YoY) +0.0% N/A
TTM Revenue (USD) $60M $357M
Market Cap $569.4M $217.2M
3. Profitability & Quality CRNT
Gross Margin 58.7% 34.1%
Operating Margin -201.0% 3.5%
Net Profit Margin -204.2% -0.3%
Return on Equity (ROE) -157.3% -0.5%
4. Balance Sheet & Cash Flow CRNT
Cash Generation (TTM) -$114M $13M
Cash Flow Margin N/A 3.6%
Net Cash / Leverage $13M Net Debt (0.79x D/E) $6.0M Net Cash
Dividend Yield None (0.00%) None (0.00%)
5. Options & Positioning SENS
Options Structure Phase CONSOLIDATION BREAKDOWN
Current IV / %ile 68.8% (35th %ile) 43.7% (7th %ile)
Put/Call OI Skew 0.14x (Call-Skewed) N/A
OBV Trend / Tech Phase ACCUMULATION · Markup ACCUMULATION · Markup
6. R&D & Supply-Chain Moat CRNT
OpEx & R&D Intensity N/A 30.6% of Rev ($109M)
90D R&D Disclosures 0 papers 0 papers
Competitive Moat Cyclical / Execution-Driven Positioning Cyclical / Execution-Driven Positioning
Supply-Chain Role Medical Devices Operator Communication Equipment Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: SENS (4) vs CRNT (6)
Institutional Metric SENS CRNT Criterion Row Edge
Market Capitalization
Scale
$569.4M $217.2M Larger Scale SENS
Trailing P/E Ratio
Valuation
21.0x 15.7x Lower Multiple CRNT
Forward P/E Ratio
Valuation
21.0x 13.7x Lower Multiple CRNT
Revenue Growth (YoY)
Growth
+141.6% +11.7% Higher Growth SENS
Operating Margin (TTM)
Profitability
-201.0% 3.5% Higher Margin CRNT
Net Profit Margin
Profitability
-204.2% -0.3% Higher Margin CRNT
Return on Equity (ROE)
Capital Efficiency
-157.3% -0.5% Higher ROE CRNT
52-Week Range Position
Momentum
68% ($5–$14) 35% ($2–$3) Stronger Trend SENS
Beta / 30D Volatility
Risk Regime
1.96β · 102% Vol 1.84β · 77% Vol Lower Realized Risk CRNT
Unified Institutional Score
Composite Signal
38.8 / 100 (SELL) 26.6 / 100 (SELL) Higher Composite SENS
Trailing 12M Revenue (USD)
Operating Scale
$60M $357M FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
58.7% 34.1% Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
N/M PEG · 9.7x EV/Rev 8.80x PEG · 0.6x EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
-$114M ($13M Net Debt (0.79x D/E)) $13M ($6.0M Net Cash) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon SENS +26.27 pp
SENS: +41.96% · CRNT: +15.69%
3M Horizon SENS +15.08 pp
SENS: +26.93% · CRNT: +11.85%
6M Horizon SENS +104.36 pp
SENS: +98.38% · CRNT: -5.98%
1Y Horizon SENS +67.16 pp
SENS: +78.48% · CRNT: +11.32%

Financial Trajectory Multi-Year Annual Revenue & Operating Margin Trajectory (USD)

Split-Invariant USD Revenue & Operating Margin (%)
Period SENS Revenue CRNT Revenue SENS Op. Margin CRNT Op. Margin Margin Leader
FY2018 $0M $340M -4295.1% 7.6% CRNT
FY2019 $0M $290M -2653.6% 2.6% CRNT
FY2020 $0M $260M -5784.4% -2.9% CRNT
FY2021 $0M $290M -4102.0% 1.7% CRNT
FY2022 $20M $300M -418.7% -3.7% CRNT
FY2023 $20M $350M -337.7% 6.1% CRNT
FY2024 $20M $390M -333.0% 9.8% CRNT
FY2025 $40M $340M -193.8% 2.1% CRNT

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
SENS CONSOLIDATION
37d in phase · OBV ACCUMULATION
Current IV 68.8%
IV Percentile 35th %ile
Put/Call OI Skew 0.14x (Call-Skewed)
IV Regime Balanced (25th–60th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal BULLISH
OBV Flow ACCUMULATION
Exact SENS Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
CRNT BREAKDOWN
114d in phase · OBV ACCUMULATION
Current IV 43.7%
IV Percentile 7th %ile
Put/Call OI Skew N/A
IV Regime Compressed (<25th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal BULLISH
OBV Flow ACCUMULATION
Exact CRNT Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
SENS Moat Profile Cyclical / Execution-Driven Positioning
Medical Devices Operator
Competes within the Medical Devices value chain with $569.4M market capitalization and -201.0% operating margin.
OpEx & R&D Reinvestment N/A
90D Engineering Disclosures 0 Published
CRNT Moat Profile Cyclical / Execution-Driven Positioning
Communication Equipment Operator
Competes within the Communication Equipment value chain with $217.2M market capitalization and 3.5% operating margin.
OpEx & R&D Reinvestment 30.6% of Rev ($109M)
90D Engineering Disclosures 0 Published

Investor FAQ SENS vs CRNT Key Questions & Quantitative Answers

As of Nov 16, 2026, Ceragon Networks Ltd (CRNT) is the stronger overall head-to-head candidate over Senseonics Holdings, Inc. (SENS) in the Tradestie Institutional Equity Comparison Engine, winning 6–4 core matrix metrics and 4–2 across our 6-pillar institutional scorecard (led by Valuation Multiples, Profitability & Quality, Balance Sheet & Cash Flow). SENS carries a Unified Composite Score of 38.8/100 (SELL) at $11.03 (21.0x Forward P/E, -201.0% operating margin), whereas CRNT carries 26.6/100 (SELL) at $2.36 (13.7x Forward P/E, 3.5% operating margin). Composite vs. Pillar Nuance: While SENS currently prints a higher short-term Unified Composite Score (38.8/100 SELL vs. CRNT 26.6/100 SELL), CRNT captures the overall institutional head-to-head verdict (6–4 matrix metrics and 4–2 across the 6 pillars) due to superior fundamental profitability (3.5% vs. -201.0% operating margin) and revenue trajectory (+11.7% vs. +141.6% YoY). Defensive Composite Rating Caution: Although CRNT compares more favorably head-to-head, both SENS (38.8/100 SELL) and CRNT (26.6/100 SELL) currently screen in defensive SELL territory (<42/100) on our Unified Composite model. Technical & Structure Timing Caution: SENS trades in a Markup technical trend (CONSOLIDATION options phase, RSI 66.7); meanwhile CRNT is in a Breakdown options structure phase (RSI 56.2). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

SENS leads the Growth & Scale pillar: SENS posts +141.6% YoY revenue growth and +0.0% YoY earnings growth on $60M TTM revenue (58.7% gross margin, -201.0% operating margin), compared with CRNT at +11.7% YoY revenue growth and N/A YoY earnings growth on $357M TTM revenue (34.1% gross margin, 3.5% operating margin). Across the 8-period historical trajectory (FY2018 to FY2025), SENS cumulative revenue shifted +100.0% while CRNT shifted +0.0%. In operating R&D and SG&A reinvestment, SENS deploys N/A (0 90-day corporate R&D disclosures) versus 30.6% of Rev ($109M) (0 disclosures) for CRNT.

CRNT screens cheaper on headline valuation multiples. SENS trades at 21.0x Forward P/E, 21.0x Trailing P/E, N/M PEG, and 9.7x EV/Revenue (unreported FCF margin), whereas CRNT trades at 13.7x Forward P/E, 15.7x Trailing P/E, 8.80x PEG, and 0.6x EV/Revenue (3.6% FCF margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against SENS (-157.3% ROE) versus CRNT (-0.5% ROE) capital efficiency.

In options market volatility and institutional positioning, SENS carries 68.8% implied volatility (35th %ile, Balanced (25th–60th %ile)), a 0.14x (Call-Skewed) Put/Call open-interest ratio, ACCUMULATION on-balance volume, and sits in a CONSOLIDATION options structure phase (1.96β · 102% Vol realized risk). By comparison, CRNT carries 43.7% implied volatility (7th %ile, Compressed (<25th %ile)), unclassified Put/Call open interest, ACCUMULATION on-balance volume, and sits in a BREAKDOWN options structure phase (1.84β · 77% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 16, 2026. For educational research only; not investment advice.